Clincosm LogoSign in Get a demo

COVITA: Containment Measures and Eating Disorders

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04492189
Collaborator
INSERM U1061 (Statistics) (Other)
40
Enrollment
1
Location
3
Actual Duration (Months)
13.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Since March 17, 2020, the French government has implemented national containment measures due to the COVID-19 epidemic. Quarantine is an unpleasant experience : Separation from relatives, loss of liberty, concern about the infectious status, boredom, can negatively affect mental health, with the emergence of anxiety and depressive symptoms.

In addition, confinement can disrupt usual physical activity, a major destabilization criterion for patients suffering from eating disorders (ED). Finally, conditions of confinement can harm social support, yet identified as a protective and resilience factor in stress contexts. Thus, the current context of confinement and social distances could be source of an increase in eating behavior disorders symptoms in people suffering from ED.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Investigators will recruit 40 patients with eating disorders. All patients were initially assessed in the daily hospital of the Endocrinology, Diabetes, Nutrition Department (Montpellier University Hospital) from January to march 2020.

    All participants will performed a phone interview to assess eating disorder symptoms, caracteristicus of containment, 1 month after the beginning of the containment, and 1 month after the end of the containment.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Impact of Containment Measures in People With Eating Disorders: a Descriptive Study
    Actual Study Start Date :
    Apr 1, 2020
    Actual Primary Completion Date :
    May 30, 2020
    Actual Study Completion Date :
    Jun 30, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Variation in eating disorders [1 month]

      the investigators aim to investigate the link between containment measures

    2. Variation in eating disorders [1 month]

      the investigators aim to investigate the link between ED symptomatology with EDE-Q (eating disorder evaluation, caractéristiques du TCA)

    Secondary Outcome Measures

    1. Vision of the bodily aspect [1 month]

      The investigators aim to investigate the link between containment measures

    2. Vision of the bodily aspect [1 month]

      The investigators aim to investigate the link between body dissatisfaction

    3. Variation in physical activity [1 month]

      the investigators aim to investigate the link between containment measures

    4. Variation in physical activity [1 month]

      the investigators aim to investigate the link between physical activity

    5. Identify the clinical factors modulating the psychological state during confinement [1 month]

      the investigators aim to investigate the link between containment measures

    6. Identify the clinical factors modulating the psychological state during confinement [1 month]

      the investigators aim to investigate the link between emotional eating

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:

    • Adult women

    • Surferring from ED

    • Assessed in the ED daily hospital (UH of Montpellier) from January to March 2020

    Exclusion criteria:

    • minors

    • refusal to participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Uhmontpellier Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier
    • INSERM U1061 (Statistics)

    Investigators

    • Study Director: Ariane SULTAN, PR, University Hospital, Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04492189
    Other Study ID Numbers:
    • RECHMPL20_0220
    First Posted:
    Jul 30, 2020
    Last Update Posted:
    Jul 30, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Feeding and Eating Disorders

    Study Results

    No Results Posted as of Jul 30, 2020